AGF Investments Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $138M | Buy |
1,025,539
+230,540
| +29% | +$33.1M | 1.3% | 18 |
|
|
2022
Q2 | $122M | Buy |
794,999
+27,266
| +4% | +$4.17M | 1.08% | 24 |
|
|
2022
Q1 | $124M | Sell |
767,733
-66,001
| -8% | -$9.59M | 0.93% | 33 |
|
|
2021
Q4 | $113M | Sell |
833,734
-40,968
| -5% | -$4.84M | 0.81% | 35 |
|
|
2021
Q3 | $94.4M | Sell |
874,702
-206,300
| -19% | -$23.6M | 0.72% | 39 |
|
|
2021
Q2 | $122M | Sell |
1,081,002
-62,104
| -5% | -$6.99M | 0.91% | 28 |
|
|
2021
Q1 | $124M | Sell |
1,143,106
-124,207
| -10% | -$13.3M | 0.98% | 20 |
|
|
2020
Q4 | $136M | Sell |
1,267,313
-35,854
| -3% | -$3.45M | 1.16% | 16 |
|
|
2020
Q3 | $114M | Buy |
1,303,167
+2,484
| +0.2% | +$234K | 1.15% | 16 |
|
|
2020
Q2 | $128M | Sell |
1,300,683
-21,065
| -2% | -$1.85M | 1.35% | 11 |
|
|
2020
Q1 | $101M | Buy |
1,321,748
+9,515
| +0.7% | +$810K | 1.22% | 18 |
|
|
2019
Q4 | $116M | Sell |
1,312,233
-31,466
| -2% | -$2.61M | 1.4% | 13 |
|
|
2019
Q3 | $102M | Sell |
1,343,699
-25,449
| -2% | -$1.74M | 1.28% | 15 |
|
|
2019
Q2 | $99.6M | Sell |
1,369,148
-263,934
| -16% | -$20.7M | 1.21% | 16 |
|
|
2019
Q1 | $132M | Sell |
1,633,082
-24,139
| -1% | -$1.97M | 1.48% | 9 |
|
|
2018
Q4 | $153M | Sell |
1,657,221
-8,815
| -0.5% | -$775K | 1.82% | 6 |
|
|
2018
Q3 | $158M | Sell |
1,666,036
-18,190
| -1% | -$1.72M | 1.59% | 8 |
|
|
2018
Q2 | $156M | Buy |
1,684,226
+168,889
| +11% | +$16.5M | 1.6% | 9 |
|
|
2018
Q1 | $143M | Buy |
1,515,337
+29,998
| +2% | +$3.3M | 1.56% | 13 |
|
|
2017
Q4 | $144M | Sell |
1,485,339
-20,554
| -1% | -$1.94M | 1.4% | 11 |
|
|
2017
Q3 | $134M | Buy |
1,505,893
+123,306
| +9% | +$9.39M | 1.46% | 10 |
|
|
2017
Q2 | $100M | Buy |
1,382,587
+24,567
| +2% | +$1.65M | 1.15% | 16 |
|
|
2017
Q1 | $88.4M | Buy |
1,358,020
+16,278
| +1% | +$1.02M | 0.96% | 24 |
|
|
2016
Q4 | $83.9M | Sell |
1,341,742
-9,863
| -0.7% | -$602K | 0.97% | 24 |
|
|
2016
Q3 | $85.2M | Sell |
1,351,605
-17,957
| -1% | -$1.16M | 0.95% | 20 |
|
|
2016
Q2 | $84.8M | Buy |
1,369,562
+118,169
| +9% | +$7.2M | 0.95% | 24 |
|
|
2016
Q1 | $71.4M | Buy |
1,251,393
+59,079
| +5% | +$3.29M | 0.86% | 29 |
|
|
2015
Q4 | $70.7M | Sell |
1,192,314
-464,802
| -28% | -$26.8M | 0.87% | 32 |
|
|
2015
Q3 | $90.6M | Sell |
1,657,116
-63,351
| -4% | -$4.12M | 1.14% | 17 |
|
|
2015
Q2 | $115M | Sell |
1,720,467
-106,114
| -6% | -$6.93M | 1.25% | 15 |
|
|
2015
Q1 | $107M | Sell |
1,826,581
-78,501
| -4% | -$4.74M | 1.16% | 19 |
|
|
2014
Q4 | $125M | Buy |
1,905,082
+649,832
| +52% | +$41M | 1.33% | 10 |
|
|
2014
Q3 | $72.6M | Buy |
+1,255,250
| New | +$69.7M | 0.75% | 36 |
|
Other funds holding ABBV
AGF Investments Inc's ABBV Position: Q3 2022 in Review
AGF Investments Inc increased its AbbVie (ABBV) stake by 29% in Q3 2022, buying an estimated $33.1M and bringing the position to 1,025,539 shares worth $138M. The position accounts for 1.3% of the portfolio, ranked #18.
AGF Investments Inc first reported a position in ABBV in Q3 2014 and has held it in 33 quarters since. The position peaked at $158M in Q3 2018. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- AGF Investments Inc held 1,025,539 shares of AbbVie worth $138M as of Q3 2022.
- AGF Investments Inc bought 230,540 AbbVie shares in Q3 2022, an estimated $33.1M.
- AbbVie made up 1.3% of AGF Investments Inc's portfolio in Q3 2022, its #18 holding.
- AGF Investments Inc first reported a position in AbbVie in Q3 2014 and has held it in 33 quarters since.
- AGF Investments Inc's AbbVie position peaked at $158M in Q3 2018.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on AGF Investments Inc's 13F filing for Q3 2022, filed 10 Nov 2022.